 monotherapy with aspirin, dual therapy with
aspirin and clopidogrel reduced risk of stroke recurrence
(RR, 0.69; 95% CI, 0.59-0.81; P < .01) and did not increase
the risk of hemorrhagic stroke (RR, 1.23; 95% CI, 0.50-3.04;
P Â¼ .65)